GNMXvsGNOMETF Comparison
VS
Corgi Genomics & Precision Medicine ETF (GNMX) and Global X Genomics & Biotechnology ETF (GNOM) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Healthcare. GNMX is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. Run a side-by-side ETF comparison of GNMX and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNMX vs GNOM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNMX GNOM | +1.85%+0.87% | n/a+17.93% | n/a+18.80% | n/a+51.85% | n/a+12.37% | n/a-38.62% |
| Flows | GNMX GNOM | -+$14M | -+$19M | -+$18M | -+$13M | --$95M | --$862K |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNMX GNOM | n/a+28.84% | n/a+26.67% | n/a+29.09% | n/a+33.32% |
| Max drawdown | GNMX GNOM | n/a-8.57% | n/a-18.16% | n/a-43.23% | n/a-72.01% |
| Max drawdown duration | GNMX GNOM | n/a18d | n/a145d | n/a905d | n/a1786d |
Trading data
GNMX | GNOM | |
Last sale 7/27/2026 at 1:30 PM | $53.69 | |
| Previous close 07/24/2026 | $53.99 | |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexGNMX | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
GNMX | GNOM | |
|---|---|---|
| Last price | – | $53.69 |
| 1D performance | – | -0.55% |
| AuM | $1.64 M | $79.16 M |
| E/R | 0.35% | 0.5% |
Characteristics
GNMX | GNOM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Corgi Funds | Global X |
| Benchmark | - | Solactive Genomics Index |
| N° of holdings | 57 | 50 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 6, 2026 | April 5, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNMX
USA
89.37%
Other
10.63%
GNOM
USA
84.1%
Other
15.9%
Sectors
GNMX
Healthcare
98.21%
Other
1.79%
GNOM
Healthcare
99.75%
Other
0.25%
Diversification
GNMX
Total weight of top 15 holdings out of 15
53.1%
GNOM
Total weight of top 15 holdings out of 15
61.22%
Top 15 holdings
Data as of June 30, 2026
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
Frequently asked questions about GNMX and GNOM
Which ETF is bigger: GNMX or GNOM?
As of July 24, 2026, GNMX holds $1.64 M in assets under management (AUM), while GNOM manages $79.16 M.
What sectors do the GNMX and GNOM ETFs invest in?
GNMX leans toward sectors like Healthcare. Meanwhile, GNOM focuses on Healthcare.
What are the top holdings of the GNMX ETF and GNOM ETF?
GNMX top holdings include Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc.. GNOM holds in its top three: Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc..
Which ETF is more diversified: GNMX or GNOM?
GNMX holds 57 securities with 53.1% of its assets in the top 15. GNOM has 50 securities and a top 15 weight of 61.22%.
Advertisement
Advertisement
